Daniel Eek

TL;DR: Evidence suggests that oncology patients prefer oral treatment to IV, and rationale for preference was due to a number of factors, including convenience, perception of efficacy, and past experience.

TL;DR: Olaparib maintenance therapy did not have a significant detrimental effect on HRQOL compared with placebo and patient-centred endpoints support the improvement in progression-free survival, the primary endpoint in SOLO2, and should be included in future trials of maintenance therapies.

TL;DR: For patients residing in community dwellings, the direct influence of patients’ cognition on caregiver burden is limited and rather mediated by other disease indicators, which means both ADL-abilities and behavioral disturbances are important predictors of perceived caregiverurden.

TL;DR: Overall, symptom severity and disability levels were comparable betweenNMOSD and MS members; however, NMOSD members were more likely than MS members to attribute disability to vision-related symptoms and were less likely to report moderate to severe cognitive and emotional symptoms.

TL;DR: In cancer and general population samples, the standard administration of PROMIS Physical Function items without a recall period is compared to administrations with 24-hour and 7-day recall periods, with no evidence of significant differences among groups in the cancer sample.